Current reports

Home > Investors > Current reports

3/2024 Medicalgorithmics US Holding will receive $0.66 million from React Group as a sale price adjustment for Medi-Lynx

2/2024 Dates of publication of periodic reports in 2024

1/2024 Information on registration of amendment to the Company’s Articles ofAssociation

36/2023 List of Shareholders Holding at Least 5% of Votes in the Total Number of Votes at the Extraordinary General Meeting of Medicalgorithmics S.A. on December 19, 2023

35/2023 Resolutions of the Extraordinary General Meeting of Medicalgorithmics S.A., which took place on December 19, 2023

3/2024 Medicalgorithmics US Holding will receive $0.66 million from React Group as a sale price adjustment for Medi-Lynx

2/2024 Dates of publication of periodic reports in 2024

1/2024 Information on registration of amendment to the Company’s Articles ofAssociation

36/2023 List of Shareholders Holding at Least 5% of Votes in the Total Number of Votes at the Extraordinary General Meeting of Medicalgorithmics S.A. on December 19, 2023

35/2023 Resolutions of the Extraordinary General Meeting of Medicalgorithmics S.A., which took place on December 19, 2023

34/2023 Adoption of final fair values for settlement of in-kind contributions in accordance with IFRS in consolidated financial statements

33/2023 Information on convening the Extraordinary General Meeting of Medicalgorithmics S.A. together with the content of draft resolutions

32/2023 Notification about Medicalgorithmics S.A.’s receipt of termination of Agreement with React

64/2022 Conclusion of an agreement for the acquisition of the Company’s shares by Biofund Capital Management LLC in accordance with the investment agreement of October 1, 2022.

62/2022 Medicalgorithmics S.A. Extraordinary General Meeting Resolutions of October 28, 2022

63/2022 List of Medicalgorithmics S.A. shareholders with 5% or more votes at the Extraordinary General Meeting of October 28, 2022

61/2022 Submission by a shareholder (i) of an application to extend the composition of the Supervisory Board of the Company to 8 persons and (ii) candidates for the Supervisory Board of the Company

60/2022 Answers to the shareholder’s questions pursuant to Art. 428 § 6 of the Commercial Companies Code.

58/2021 Notification of a Shareholder on a change in a share in the share capital and in the total number of votes in the Company

57/2021 Notification of a Shareholder on a change in a share in the share capital and in the total number of votes in the Company

55/2021 Receipt of aid funds in the amount of USD 1.9 million (PLN 7.8 million) by a subsidiary of the Issuer

54/2021 Registration of the share capital increase

53/2021 Information on the number of payment requests from insurers submitted in November 2021

47/2020 Conclusion by the Issuer’s subsidiary of an agreement for the purchase of 25% of units in Medi-Lynx and setting forth the conditions for payment of a promissory note

46/2020 Information on the number of payment requests from insurers submitted in November 2020

45/2020 Disbursement of the loan taken by the Company from Bank Millenium S.A.

44/2020 Information on the number of payment requests from insurers submitted in October 2020

43/2020 Conclusion of a significant contract by a subsidiary

43/2019 Information on the number of payment requests from insurers submitted in November 2019

41/2019 Announcement on convening the Extraordinary General Meeting of Medicalgorithmics S.A.

42/2019 Contents of draft resolutions for the Extraordinary General Meeting of Medicalgorithmics S.A. convened for 7 January 2020

40/2019 Decisions made in the course of the strategic options review

39/2019 Information on the number of payment requests from insurers submitted in October 2019

39/2018 Information on the number of payment requests from insurers submitted in November 2018

38/2018 Receipt of notification from a shareholder under Article 69 of the Act on Public Offering

37/2018 Information on the number of payment requests from insurers submitted in October 2018

36/2018 Appointment of CEO of Medi-Lynx Cardiac Monitoring, LLC

35/2018 Information on the number of payment requests from insurers submitted in September 2018

36/2017 Conclusion of a co-financing agreement with the National Centre for Research and Development

35/2017 Information on the number of payment requests from insurers submitted by Medi-Lynx Cardiac Monitoring, LLC in November 2017

34/2017 Registration of amendments to the Articles of Association of Medicalgorithmics S.A.

33/2017 Receipt of notification from a shareholder under Article 69 of the Act on Public Offering

32/2017 Information on the number of payment requests from insurers submitted by Medi-Lynx Cardiac Monitoring, LLC in October 2017

Current reports

3/2024 Medicalgorithmics US Holding will receive $0.66 million from React Group as a sale price adjustment for Medi-Lynx

2/2024 Dates of publication of periodic reports in 2024

1/2024 Information on registration of amendment to the Company’s Articles ofAssociation

36/2023 List of Shareholders Holding at Least 5% of Votes in the Total Number of Votes at the Extraordinary General Meeting of Medicalgorithmics S.A. on December 19, 2023

35/2023 Resolutions of the Extraordinary General Meeting of Medicalgorithmics S.A., which took place on December 19, 2023

3/2024 Medicalgorithmics US Holding will receive $0.66 million from React Group as a sale price adjustment for Medi-Lynx

2/2024 Dates of publication of periodic reports in 2024

1/2024 Information on registration of amendment to the Company’s Articles ofAssociation

36/2023 List of Shareholders Holding at Least 5% of Votes in the Total Number of Votes at the Extraordinary General Meeting of Medicalgorithmics S.A. on December 19, 2023

35/2023 Resolutions of the Extraordinary General Meeting of Medicalgorithmics S.A., which took place on December 19, 2023

34/2023 Adoption of final fair values for settlement of in-kind contributions in accordance with IFRS in consolidated financial statements

33/2023 Information on convening the Extraordinary General Meeting of Medicalgorithmics S.A. together with the content of draft resolutions

32/2023 Notification about Medicalgorithmics S.A.’s receipt of termination of Agreement with React

64/2022 Conclusion of an agreement for the acquisition of the Company’s shares by Biofund Capital Management LLC in accordance with the investment agreement of October 1, 2022.

62/2022 Medicalgorithmics S.A. Extraordinary General Meeting Resolutions of October 28, 2022

63/2022 List of Medicalgorithmics S.A. shareholders with 5% or more votes at the Extraordinary General Meeting of October 28, 2022

61/2022 Submission by a shareholder (i) of an application to extend the composition of the Supervisory Board of the Company to 8 persons and (ii) candidates for the Supervisory Board of the Company

60/2022 Answers to the shareholder’s questions pursuant to Art. 428 § 6 of the Commercial Companies Code.

58/2021 Notification of a Shareholder on a change in a share in the share capital and in the total number of votes in the Company

57/2021 Notification of a Shareholder on a change in a share in the share capital and in the total number of votes in the Company

55/2021 Receipt of aid funds in the amount of USD 1.9 million (PLN 7.8 million) by a subsidiary of the Issuer

54/2021 Registration of the share capital increase

53/2021 Information on the number of payment requests from insurers submitted in November 2021

47/2020 Conclusion by the Issuer’s subsidiary of an agreement for the purchase of 25% of units in Medi-Lynx and setting forth the conditions for payment of a promissory note

46/2020 Information on the number of payment requests from insurers submitted in November 2020

45/2020 Disbursement of the loan taken by the Company from Bank Millenium S.A.

44/2020 Information on the number of payment requests from insurers submitted in October 2020

43/2020 Conclusion of a significant contract by a subsidiary

43/2019 Information on the number of payment requests from insurers submitted in November 2019

41/2019 Announcement on convening the Extraordinary General Meeting of Medicalgorithmics S.A.

42/2019 Contents of draft resolutions for the Extraordinary General Meeting of Medicalgorithmics S.A. convened for 7 January 2020

40/2019 Decisions made in the course of the strategic options review

39/2019 Information on the number of payment requests from insurers submitted in October 2019

39/2018 Information on the number of payment requests from insurers submitted in November 2018

38/2018 Receipt of notification from a shareholder under Article 69 of the Act on Public Offering

37/2018 Information on the number of payment requests from insurers submitted in October 2018

36/2018 Appointment of CEO of Medi-Lynx Cardiac Monitoring, LLC

35/2018 Information on the number of payment requests from insurers submitted in September 2018

36/2017 Conclusion of a co-financing agreement with the National Centre for Research and Development

35/2017 Information on the number of payment requests from insurers submitted by Medi-Lynx Cardiac Monitoring, LLC in November 2017

34/2017 Registration of amendments to the Articles of Association of Medicalgorithmics S.A.

33/2017 Receipt of notification from a shareholder under Article 69 of the Act on Public Offering

32/2017 Information on the number of payment requests from insurers submitted by Medi-Lynx Cardiac Monitoring, LLC in October 2017

Your submission was succesfull